Christopher Peetz, CHIEF EXECUTIVE OFFICER at Mirum Pharmaceuticals, Inc. (MIRM), sold 20,000 shares at $98.51 ($2.0M) on 2026-08-10, disclosed to the SEC on 2026-08-11.
Scheduled sale ($2.0M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.51 | 11,683 | $1.2M | 58.2% |
| 2 | $99.25 | 6,017 | $597K | 30.2% |
| 3 | $100.14 | 2,300 | $230K | 11.6% |
| Total | $98.92 avg | 20,000 | $2.0M | 100% |
| Filing → |
| MIRM | SELL | 2026-06-02 | $2.9M | — | Filing → |
| MIRM | SELL | 2026-03-17 | $7.5M | — | Filing → |
| MIRM | SELL | 2026-02-03 | $941K | — | Filing → |